Mechanisms of the Cardiotoxic Action of Amitriptyline
https://doi.org/10.15360/1813-9779-2011-6-24
Abstract
Objective: to study the mechanisms of toxic action of amitriptyline on the myocardium. Material and methods. Investigations were conducted using the hearts from 30 outbred albino rats, which had been isolated and perfused according to the procedure described by Fallen et al. There were two series of experiments: 1) amitriptyline was added in a dose of 250 ng/ml to Krebs-Henseleit solution (Group 1); 2) the agent was added at another concentration (1250 ng/ml) to the solution passing through the coronary bed (Group 2). The animals were anesthetized with thiopental sodium (25 mg/kg) peritoneally. Results. Amitriptyline depresses myocardial contractility, which is particularly obvious with high-rate pacing. This manifests itself as reduced contractile velocity and force-power parameters and elevated left ventricular diastolic pressure. Amitriptyline lowers the efficacy of glucose and increases the release of enzymes into the coronary duct. Conclusion. Hypoergosis, membrane destruction, and cardiomyocyte ion pump failure have been shown to underlie negative chronotropic and inotropic effects in amitriptyline poisoning. Key words: amitriptyline, acute poisoning, isolated heart, myocardial damage.
References
1.
2. Kisely S, Cox M, Campbell L. A. et al. An epidemiologic study of psychotropic medication and obesity-related chronic illnesses in older psychiatric patients. Can. J. Psychiatry 2009; 54 (4): 269—274.
3. Fallen E. L., Elliott W. C., Gorlin R. Apparatus for study of ventricular function and metabolism in the isolated perfused rat heart. J. Appl. Phisiol. 1967; 22 (4): 836—839.
4. Долгих В. Т. Повреждение и защита сердца при острой смертельной кровопотере. Омск; 2002.
5. Miyamoto S., Duncan G. E., Marx C. E., Lieberman J. A. Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs. Mol. Psychiatry 2005; 10 (1): 79—104.
6. Seger D. L. A critical reconsideration of the clinical effects and treatment recommendations for sodium channel blocking drug cardiotoxici-ty. Toxicol. Rev. 2006; 25 (4): 283—29
7. Somberg T. C., Arora R. R. Depression and heart disease: therapeutic implications. Cardiology 2008; 111 (2): 75—81.
8. Zemrak W. R., Kenna G. A.Association of antipsychotic and antidepres-sant drugs with Q-T interval prolongation. Am. J. Health Syst. Pharm. 2008; 65 (11): 1029—103
9. Долгих В. Т.Повреждение и защита сердца при острой смертельной кровопотере. Бюл. СО РАМН 2001; 1: 73—81.
10. Langou R. A., Van Dyke C., Tahan S. R., Cohen L. S.Cardiovascular manifestations of tricyclic antidepressant overdose. Am. Heart J. 1980; 100 (4): 458—464.
11. Takehara N., Makita N., Kawabe J. et al.A cardiac sodium channel mutation identified in Brugada syndrome associated with atrial standstill. J. Intern. Med. 2004; 255 (1): 137—142.
12. Gurevitz O., Glikson M.Cardiac resynchronization therapy: A new frontier in the management of heart failure. Isr. Med. Assoc. J. 2003; 5 (8): 571—575.
13. Щербакова Л. Н., Чернышева Г. Г., Никифоров Ю. В., Молчанова Л. В.Лип оп роте иды крови при хирургической реваскуляризаци миокарда. Общая реаниматология 2008; IV(2): 33—37.
Review
For citations:
Chekmarev G.V., Dolgikh V.T. Mechanisms of the Cardiotoxic Action of Amitriptyline . General Reanimatology. 2011;7(6):24. (In Russ.) https://doi.org/10.15360/1813-9779-2011-6-24
Views:
2323
Email this article 